2Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics [J]. Pediatr Infect Dis J, 1997, 16 (8): 746-747.
3Benitz WE, Han MY, Madan A, et al. Serial serum C-reactive protein levels in the diagnosis of neonatal infection [J]. Pediatrics,1998, 102 (4): E41.
4Patrick N, Pulliam M, Attia W. C-reactive protein in febrile children 1 to 36 months of age with clinically undectable serious bacterial infection [J]. Pediatrics, 2001, 108 (6): 1275-1279.
5Fermandez LA, Luaces CC, Careia GJJ, et al. Procalcitonin in pediatric emergency department for the early diagnosis of invasive bacterial infection in febrile: results of a multicenter study and utility of a rapid qualitative test for this marker [ J]. Pediatr Infect Dis,2003. 22 (4) : 895-903.
6Wyllie DH, Bowler ICJW, Petot EA. Bacteraemia prediction in emergency medical admissions: role of C reactive protein [J]. J Clin Pathol, 2005, 58 (4): 352-356.
7Arkader R, Troster El, Lopes MR. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome [ J ].Arch Dis Child, 2006, 91 (2): 117-120.
8Michael Meisner. Biomarkers of sepsis: clinically useful? [J]. Curr Opin Crit Care, 2005, 11 (5) : 473-480.
9Baker MD, Avner JR, Bell LM. Failure of infant observation scales in detecting serious illness in febrile, 4-to 8-week-old infants [ J].Pediatrics, 1990, 85 (6): 1040-1043.
10Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone [J]. J Pediatr, 1992, 120 (1): 22-27.
